1. Introduction {#sec1-marinedrugs-17-00004}
===============

Fungi are an important resource of structurally and biologically diverse substances for drug and pesticide discovery \[[@B1-marinedrugs-17-00004],[@B2-marinedrugs-17-00004],[@B3-marinedrugs-17-00004],[@B4-marinedrugs-17-00004],[@B5-marinedrugs-17-00004],[@B6-marinedrugs-17-00004],[@B7-marinedrugs-17-00004]\]. A set of rare natural compounds from fungi, such as talaroconvolutins A-D, ZG-1494R, oteromycin, and codinaeopsin, which contain a modified tetramic acid unit linked to phenol, benzene, or indole and decalin fragments, exhibit activities against fungi, platelet-activating factors, acetyltransferase, endothelins receptors, or *Plasmodium falciparum* \[[@B8-marinedrugs-17-00004],[@B9-marinedrugs-17-00004],[@B10-marinedrugs-17-00004],[@B11-marinedrugs-17-00004]\]. During our ongoing search for new bioactive metabolites from marine fungi, *Cladosporium* sp. HNWSW-1 was isolated from the healthy tree root of *Ceriops tagal* collected from the Dong Zhai Gang Mangrove Reserve in Hainan. The secondary metabolites of the genus *Cladosporium* have been mainly reported as polyketides derivatives, such as fatty acids \[[@B12-marinedrugs-17-00004]\], macrolides \[[@B13-marinedrugs-17-00004],[@B14-marinedrugs-17-00004],[@B15-marinedrugs-17-00004]\], pyrones \[[@B16-marinedrugs-17-00004],[@B17-marinedrugs-17-00004],[@B18-marinedrugs-17-00004]\], binaphthyl derivatives \[[@B19-marinedrugs-17-00004],[@B20-marinedrugs-17-00004]\], α-pyridone \[[@B21-marinedrugs-17-00004]\] and tetramic acid derivatives \[[@B22-marinedrugs-17-00004],[@B23-marinedrugs-17-00004]\]. Subsequent chemical investigations on the EtOAc extract of its fermentation cultures led to the isolation of cladosporitins A (**1**) and B (**2**), which contain the succinimide unit linked to phenol and decalin fragments. In addition, a new pyrone, clapone (**3**), was also isolated along with the previously reported talaroconvolutin A (**4**) \[[@B8-marinedrugs-17-00004]\] and 1,3,6-trihydroxy-7-(1-hydroxyethyl) anthracene-9,10-dione (**5**) \[[@B24-marinedrugs-17-00004]\]. Herein, we describe the isolation, structural determination, and biological activities of compounds **1**--**5**.

2. Results {#sec2-marinedrugs-17-00004}
==========

2.1. Structural Elucidation {#sec2dot1-marinedrugs-17-00004}
---------------------------

Compound **1** was isolated as yellow oil. Its molecular formula was determined as C~32~H~43~NO~4~ by HRESIMS *m*/*z* 528.3103 \[M + Na\]^+^ (calcd. for C~32~H~43~NO~4~Na 528.3084) ([Figure S18 in Supplementary Materials](#app1-marinedrugs-17-00004){ref-type="app"}). The ^1^H, DEPTQ and HSQC NMR spectra ([Figures S1, S2, and S6](#app1-marinedrugs-17-00004){ref-type="app"}[--S8 in Supplementary Materials](#app1-marinedrugs-17-00004){ref-type="app"}) of compound **1** showed signals of one ketone carbonyl at *δ*~C~ 203.9, two amide carbonyls at *δ*~C~ 172.7 and *δ*~C~ 179.2, a *para*-substituted benzene ring (*δ*~C~ 131.5/ *δ*~H~ 7.10, *δ*~C~ 116.3/*δ*~H~ 6.77, *δ*~C~ 157.5 and *δ*~C~ 128.1), seven *sp^3^* methines (*δ*~C~ 61.7, *δ*~C~ 52.9, *δ*~C~ 51.8, *δ*~C~ 45.0, *δ*~C~ 40.8, *δ*~C~ 34.8, and *δ*~C~ 28.1), two *sp^2^* methines (*δ*~C~ 137.1 and *δ*~C~ 136.7), five methylenes (*δ*~C~ 49.1, *δ*~C~ 36.5, *δ*~C~ 35.8, *δ*~C~ 31.1, and *δ*~C~ 24.1), and six methyls (*δ*~C~ 23.1, *δ*~C~ 22.5, *δ*~C~ 21.1, *δ*~C~ 20.5, *δ*~C~ 15.2, and *δ*~C~ 12.4) ([Table 1](#marinedrugs-17-00004-t001){ref-type="table"}), except in the above data there were also three quaternary carbons (*δ*~C~ 130.7, *δ*~C~ 135.7, and *δ*~C~ 36.2). The comparison of ^1^H and ^13^C NMR data ([Table 1](#marinedrugs-17-00004-t001){ref-type="table"}) of the previously reported talaroconvolutin A (**4**) \[[@B8-marinedrugs-17-00004]\] revealed many similarities. Compound **1** had the same decalin moiety with the substituent that is the 4-methylhex-2-en-2-yl substituent linked to C-15 (*δ*~C~ 51.8) as compound **4**. This is evidenced by the sequential COSY correlations ([Figures S3--S5 in Supplementary Materials](#app1-marinedrugs-17-00004){ref-type="app"}) from H-15 (*δ*~H~ 3.10) through H~3~-33 (*δ*~H~ 0.82), and H~2~-18 (*δ*~H~ 1.48/0.87), from H~3~-28 (*δ*~H~ 0.86) through H-25 (*δ*~H~ 5.05) and H~3~-29 (*δ*~H~ 0.92), as well as by HMBC correlations ([Figures S9--S14 in Supplementary Materials](#app1-marinedrugs-17-00004){ref-type="app"}) from H-14 (*δ*~H~ 3.62) to C-23 (*δ*~C~ 36.2), and C-24 (*δ*~C~ 135.7), from H-15 to C-17 (*δ*~C~ 137.1), C-22 (*δ*~C~ 40.8), C-24, C-30 (*δ*~C~ 15.2), and C-31 (*δ*~C~ 22.5), from H-17 (*δ*~H~ 5.38) to C-15, C-18 (*δ*~C~ 49.1), C-31, and C-32 (*δ*~C~ 20.5), from H~2~-18 to C-20 (*δ*~C~ 36.5), C-22, and C-33 (*δ*~C~ 23.1), from H-22 (*δ*~H~ 1.78) to C-20, C-21 (*δ*~C~ 24.1), and C-23, from H~3~-31 (*δ*~H~ 1.54) to C-15, C-16 (*δ*~C~ 130.7), and C-17, from H~3~-33 to C-18 and C-20, from H~3~-32 (*δ*~H~ 0.91) to C-17, C-18, C-22, and C-23, from H-25 to C-15, C-26 (*δ*~C~ 34.8), C-27 (*δ*~C~ 31.1), C-29 (*δ*~C~ 21.1), and C-30 (*δ*~C~ 15.2), from H-26 (*δ*~H~ 2.25) to C-27, C-28 (*δ*~C~ 12.4), and C-29, as well as from H~3~-29 to C-25 (*δ*~C~ 136.7), C-26, and C-27. The differences between compounds **1** and **4** are that the modified tetramic acid unit, 1,5-dihydro-2*H*-pyrrol-2-one unit, and C-6/C -7 double bond in compound **4** were replaced by the succinimide unit and CH~2~-6/CH-7 unit in compound **1**, respectively, as deduced by the sequential COSY correlations ([Figures S3--S5 in Supplementary Materials](#app1-marinedrugs-17-00004){ref-type="app"}) from H-3 (*δ*~H~ 4.06) to H~2~-6 (*δ*~H~ 3.11/2.87) through H-4 (*δ*~H~ 3.40) and the HMBC correlations ([Figures S9--S14 in Supplementary Materials](#app1-marinedrugs-17-00004){ref-type="app"}) from H-3 to C-2 (*δ*~C~ 172.7)/C-4 (*δ*~C~ 45.0)/C-5 (*δ*~C~ 179.2)/C-6 (*δ*~C~ 35.8), from H-4 to C-2/C-3 (*δ*~C~ 61.7)/C-5/C-6/C-7 (*δ*~C~ 128.1), and from H~2~-6 to C-3/C-4/C-5/C-7/C-8 (*δ*~C~ 131.5). In addition, the COSY and HMBC correlations suggested that the *para*-disubstituted benzene ring was linked to C-4 in compound **1** via C-6. Finally, the key HMBC correlations from H-3 and H-4 to C-13 (*δ*~C~ 203.9) and from H-14 to C-13 confirmed that the decalin and the succinimide fragments were linked through a ketone carbonyl (C-13). According to the molecular formula and the chemical shift of C-10 (*δ*~C~ 157.5) in compound **1**, a hydroxyl group was present on C-10. ROESY correlations ([Figures S15--S17 in Supplementary Materials](#app1-marinedrugs-17-00004){ref-type="app"}) from H-14 and H-19 to H~3~-32 suggested the relative configurations of C-14, C-19, and C-23 as shown in [Figure 1](#marinedrugs-17-00004-f001){ref-type="fig"}. The large coupling constant (*J* = 12.0 Hz) of H-14/H-22 indicated their *trans*-diaxial orientation, while a coupling constant of 7.0 Hz between H-14 and H-15 placed these two protons in an axial-equatorial orientation \[[@B9-marinedrugs-17-00004],[@B11-marinedrugs-17-00004]\]. Moreover, the ROESY correlation from H-3 to H~2~-6 (*δ*~H~ 2.87) hinted that H-3 and H-4 were on opposite sides of the succinimide ring. ROESY correlations ([Figures S15--S17 in Supplementary Materials](#app1-marinedrugs-17-00004){ref-type="app"}) from H~3~-30 to H-26 and from H-25 to H-15 proved the *E*-configuration of Δ^24^ double bond. Thus, the structure of compound **1** was established as shown in [Figure 1](#marinedrugs-17-00004-f001){ref-type="fig"} and was named cladosporitin A. However, the relative relationship between the chiral carbons in the succinimide fragment and those in the decalin fragment cannot be determined due to the free rotation of the C-3/C-13/C-14 linkage.

Compound **2** was also isolated as a yellow oil with the same molecular formula as compound **1**, as determined by the HRESIMS peak at *m*/*z* 506.3279 \[M + H\]^+^ (calcd. for C~32~H~44~NO~4~ 506.3265) ([Figure S39 in Supplementary Materials](#app1-marinedrugs-17-00004){ref-type="app"}). A detailed comparison of NMR data of compound **2** ([Figures S19--S36 in the Supplementary Materials](#app1-marinedrugs-17-00004){ref-type="app"} and [Table 1](#marinedrugs-17-00004-t001){ref-type="table"}) with those of compound **1** indicated that compound **2** had the same planar structure as compound **1**. ROESY correlations ([Figures S37 and S38 in Supplementary Materials](#app1-marinedrugs-17-00004){ref-type="app"} and [Figure 2](#marinedrugs-17-00004-f002){ref-type="fig"}) from H-14 and H-19 to H~3~-32 along with the coupling constant of H-14/H-22 (*J* = 12.1 Hz) and H-14/H-15 (*J* = 6.9 Hz) suggested that the relative configurations of C-14, C-15, C-19, C-22, and C-23 in the decalin fragment of compound **2** were the same as those of compound **1**. However, the relatively large coupling constant between H-3 and H-4 of compound **2** (*J* = 4.1 Hz) compared to compound **1** (*J* = 2.4 Hz) combined with the absence of the ROESY correlation of H-3/H~2~-6 (*δ*~H~ 3.10/2.79) in compound **2** suggested the *cis* orientation of H-3 and H-4, which is different than that of compound **1**. Thus, compound **2** was elucidated as shown in [Figure 1](#marinedrugs-17-00004-f001){ref-type="fig"} and named cladosporitin B.

Compound **3**, a yellow oil, exhibited a prominent sodium adduct ion peak at *m/z* 239.0676 \[M + Na\]^+^ in the HRESIMS spectrum ([Figure S50 in Supplementary Materials](#app1-marinedrugs-17-00004){ref-type="app"}), suggesting a molecular formula of C~13~H~12~O~3~. Analysis of ^1^H NMR, ^13^C NMR, and HSQC spectra ([Figures S40--S42 and S44--46 in Supplementary Materials](#app1-marinedrugs-17-00004){ref-type="app"}) displayed five aromatic or olefinic methines (*δ*~C~ 137.3/*δ*~H~ 6.86, *δ*~C~ 124.8/*δ*~H~ 6.26, *δ*~C~ 118.3/*δ*~H~ 6.64, *δ*~C~ 109.9/*δ*~H~ 6.01, and *δ*~C~ 101.8/*δ*~H~ 6.70), two methyl siglets (*δ*~C~ 23.1/*δ*~H~ 2.73 and *δ*~C~ 18.6/*δ*~H~ 1.99), three sp^2^ oxyquaternary carbons (*δ*~C~ 164.0, *δ*~C~ 162.0, and *δ*~C~ 161.0), two sp^2^ quaternary carbons (*δ*~C~ 143.6 and *δ*~C~ 115.8), and one carbonyl (*δ*~C~ 182.3) ([Table 2](#marinedrugs-17-00004-t002){ref-type="table"}). The ^1^H NMR and ^13^C NMR data of compound **3** ([Table 2](#marinedrugs-17-00004-t002){ref-type="table"}) were very similar to those of 7-hydroxy-5-methyl-2- (2-oxobutyl)-4*H*-chromen-4-one \[[@B25-marinedrugs-17-00004]\]. The only major difference between them was the substituent linked to the 7-hydroxy-5-methyl-4*H*-chromen-4-one nucleus on C-2. The COSY correlations ([Figure S43 in Supplementary Materials](#app1-marinedrugs-17-00004){ref-type="app"}) of H-1′ (*δ*~H~ 6.26)/H-2′ (*δ*~H~ 6.86)/ H-3′ (*δ*~H~ 1.99), along with the HMBC correlations ([Figures S47--S49 in Supplementary Materials](#app1-marinedrugs-17-00004){ref-type="app"} and [Figure 3](#marinedrugs-17-00004-f003){ref-type="fig"}) from H-1′ to C-2 (*δ*~C~ 162.0) and C-3′ (*δ*~C~ 18.6), from H-2′ to C-2 and C-3′, as well as from H-3 to C-1′ (*δ*~C~ 124.8) proved that a propylene fragment was located at C-2 in compound **3**. In addition, the large coupling constant (*J* = 15.6) between H-1′ and H-2′ deduced the *E*-configuration of Δ^1′^ double bond. Hence, compound **3** was identified and named clapone.

2.2. The Bioactivities of Compounds **1**--**5** from Cladosporium sp. HNWSW-1 {#sec2dot2-marinedrugs-17-00004}
------------------------------------------------------------------------------

Compounds **1**--**5** were tested for their cytotoxicity against Hela, BEL-7042, K562 and SGC-7901 cell lines ([Table 3](#marinedrugs-17-00004-t003){ref-type="table"}). Compound **2** showed cytotoxicity against the BEL-7042, K562 and SGC-7901 cell lines with IC~50~ values of 29.4 ± 0.35 μM, 25.6 ± 0.47 μM and 41.7 ± 0.71 μM, respectively. Compound **4** exhibited cytotoxicity against Hela and BEL-7042 cell lines with IC~50~ values of 14.9 ± 0.21 μM and 26.7 ± 1.1 μM, respectively. In addition, all of the compounds were tested for their inhibitory activity against α-glycosidase ([Table 3](#marinedrugs-17-00004-t003){ref-type="table"}). Only compounds **4** and **5** displayed the inhibitory activity against α-glycosidase, with IC~50~ values of 78.2 ± 2.1 μM and 49.3 ± 10.6 μM, respectively.

3. Materials and Methods {#sec3-marinedrugs-17-00004}
========================

3.1. General Experimental Procedures {#sec3dot1-marinedrugs-17-00004}
------------------------------------

Silica gel (60--80, 200--300 mesh, Qingdao Marine Chemical Co. Ltd., Qingdao, China), ODS gel (20--45 μm, Fuji Silysia Chemical Co. Ltd., Aichi-ken, Japan,), and Sephadex LH-20 (Merck, Kenilworth, NJ, USA) were used for column chromatography. TLC was conducted on precoated silica gel G plates (Qingdao Marine Chemical Co. Ltd., Qingdao, China), and spots were detected by spraying with 5% H~2~SO~4~ in EtOH followed by heating. Optical rotations were measured on a Rudolph Autopol III polarimeter (Rudolph Research Analytical, NJ, USA). IR absorptions were obtained on a Nicolet 380 FT-IR instrument (Thermo, Waltham, MA, USA) using KBr pellets. 1D and 2D NMR spectra were recorded on Bruker AV III spectrometer (Bruker, Billerica, MA, USA) (^1^H NMR at 500 MHz and ^13^C NMR at 125 MHz for **2**--**5**, ^1^H NMR at 600 MHz and ^13^C NMR at 150 MHz for compound **1**) using TMS as the internal standard. HRESIMS spectra were recorded with Agilent 6200/6500 iFunnel Q-TOF. Semipreparative HPLC was carried out using an ODS column (YMC-pack ODS-A, 10 × 250 mm, 5*μ*m, 4 mL/min). Chem3D Pro 14.0 was the software used for building these 3D models and the calculation method used for energy minimizations.

3.2. Fungal Material {#sec3dot2-marinedrugs-17-00004}
--------------------

The strain HNWSW-1 of *Cladosporium* sp. was isolated from the healthy tree root of *Ceriops tagal*, which was collected in the Dong Zhai Gang Mangrove Reserve in Hainan province in July 2011. A healthy root sample of *Ceriops tagal* was washed in running tap water to remove adhered epiphytes and soil debris. The root surface was sterilized by sequential immersion in 75% (*v*/*v*) ethanol for 3 min and 5% sodium hypochlorite solution for 5 min after drying under sterile conditions, washing the surface-treated roots three times in sterile distilled water after each sterilization. Next, air-dried sterilized roots were cut into about 0.5 cm × 0.5 cm cubes, deposited on a Potato Dextrose Agar (PDA) (200 g potato, 20 g glucose, 20 g agar per liter of seawater collected in Haikou Bay, China) plate containing chloramphenicol (100 μg/mL) as a bacterial inhibitor. A reference culture is maintained in our laboratory at −80 °C. Working stocks were prepared on PDA slants stored at 4 °C.

The fungus was identified based on the DNA sequences (GenBank access No. MH 535968, the the 18S rRNA gene sequences data in [Supplementary Materials](#app1-marinedrugs-17-00004){ref-type="app"}) of 18Sr DNA genes. The mycelium was ground to a fine powder in liquid N~2~, then genomic DNA was extracted, and the 18S rDNA region was amplified by PCR using primers NS1 (5′-GTAG TCATATGCTTGTCTC-3′) and NS6 (5′-GCATCACAGACCTGTTATTGCCT C-3′). PCR products were sequenced (Applied Biosystems 3730 XL Genetic Analyzer, Applied Biosystems Inc., Foster City, CA, USA).

3.3. Fermentation and Extraction {#sec3dot3-marinedrugs-17-00004}
--------------------------------

*Cladosporium* sp. HNWSW-1 was cultured in PDB (the potato liquid media consisting of 200.0 g/L potato, 20.0 g/L glucose, and 1000 mL deionized water) at 28 °C and 150 rpm for 72 h. Then 5 mL seed broth was transferred aseptically to 1000 ml Erlenmeyer flasks (60 flasks), each containing rice medium (80 g rice and 160 mL water). The flasks were incubated at room temperature under static conditions for 60 days. The cultures were extracted three times by EtOAc, and the EtOAc solutions were combined and evaporated under reduced pressure to produce a dark brown gum (7.1 g).

3.4. Purification and Identification {#sec3dot4-marinedrugs-17-00004}
------------------------------------

The obtained EtOAc crude extract (7.1 g) was fractionated into 12 fractions (Fr.1--Fr.12) on silica gel VLC and eluted with a gradient elution of CH~2~Cl~2~-petroleum ether (0--100%) and MeOH-CH~2~Cl~2~ (0--100%). Fr.6 (2.4 g) was fractionated by RP-18 column chromatography with a gradient of water-MeOH to give 25 fractions (Fr.6.1--Fr.6.25). Fr.6.9 (118.2 mg) was purified by a sephadex LH-20 column (40 g) and eluted with MeOH and acetone, respectively, then further submitted to HPLC purification on ODS column eluting with 90% MeOH to yield compounds **1** (1.0 mg) and **2** (2.1 mg). Fr.6.10 (72.6 mg) was separated by a sephadex LH-20 column (40 g) and eluted with MeOH to yield **4** (2.0 mg). Fr.8 (853.1 mg) was submitted to an RP-18 column and eluted with MeOH-Water to give 7 fractions (Fr.8.1--Fr.8.7). Fr.8.2 (25.2 mg) was separated by a sephadex LH-20 column (15 g) and eluted with MeOH and further submitted to HPLC purification on ODS column eluted with 35% MeCN to yield **3** (0.6 mg) and **5** (2.2 mg).

Cladosporitin A (**1**): Yellow oil;$\left\lbrack \alpha \right\rbrack_{D}^{20}$---166.6 (*c* 0.01, CHCl~3~); IR (KBr) ν~max~: 3290, 2926,1711,1515 cm^−1^; HRESIMS: *m/z* 528.3103 \[M + Na\]^+^ (calcd. for C~32~H~43~NO~4~Na, 528.3084); ^1^H and ^13^C NMR data: See [Table 1](#marinedrugs-17-00004-t001){ref-type="table"}.

Cladosporitin B (**2**): Yellow oil; $\left\lbrack \alpha \right\rbrack_{D}^{20}$---94.5 (*c* 0.11, CHCl~3~); IR (KBr) ν~max~: 3247, 2956, 1713, 1515 cm^−1^; HRESIMS: *m*/*z* 506.3279 \[M + H\]^+^ (calcd. for C~32~H~44~NO~4~, 506.3265); ^1^H and ^13^C NMR data: See [Table 1](#marinedrugs-17-00004-t001){ref-type="table"}.

Clapone (**3**): Yellow oil; IR (KBr) ν~max~: 3435, 2978, 1673, 1400 cm^−1^; HRESIMS: *m*/*z* 239.0676 \[M + Na\]^+^ (calcd. for C~13~H~12~O~3~Na, 239.0679); ^1^H and ^13^C NMR data: See [Table 2](#marinedrugs-17-00004-t002){ref-type="table"}.

3.5. Bioassays for Cytotoxic Activity {#sec3dot5-marinedrugs-17-00004}
-------------------------------------

The MTT method optimized by Mosmann et al. \[[@B26-marinedrugs-17-00004]\] was performed in vitro to test the cytotoxic activity of compounds 1--6. Adriamycin was used as a positive control and the medium without the test compound was used as a negative control in the bioassay.

3.6. Bioassays for α-Glycosidase Inhibitory Activity {#sec3dot6-marinedrugs-17-00004}
----------------------------------------------------

The method optimized by Jong et al. \[[@B27-marinedrugs-17-00004]\] was performed in vitro to test the α-glucosidase inhibitory activity of compounds 1--5. Acarbose was used as positive control.

4. Conclusions {#sec4-marinedrugs-17-00004}
==============

Three new compounds (**1**--**3**) along with the previously reported talaroconvolutin A (**4**) and anthraquinone (**5**) were isolated from the rice medium culture of mangrove-derived fungus *Cladosporium* sp. HNWSW-1, isolated from the healthy root of *Ceriops tagal* collected in the Dong Zhai Gang Mangrove Reserve in Hainan. Their structures were determined by spectroscopic methods. Compound **2** showed cytotoxicity against BEL-7042, K562 and SGC-7901 cell lines with IC~50~ values of 29.4 ± 0.35 μM, 25.6 ± 0.47 μM, and 41.7 ± 0.71 μM, respectively, while compound **4** exhibited cytotoxicity against the Hela and BEL-7042 cell lines with IC~50~ values of 14.9 ± 0.21 μM and 26.7 ± 1.1 μM, respectively. Moreover, compounds **4** and **5** displayed inhibitory activity against α-glycosidase with IC~50~ values of 78.2 ± 2.1 μM and 49.3 ± 10.6 μM, respectively. The results suggested that the mangrove-derived fungi are an important source of new bioactive substances.

The NMR and HRESIMS spectra for **1**--**3** are available online at <http://www.mdpi.com/1660-3397/17/1/4/s1>.

###### 

Click here for additional data file.
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###### 

^1^H and ^13^C NMR Data for compound **1** (600 and 150 MHz, δ in ppm) and compound **2** (500 and 125 MHz, δ in ppm).

  ----------------------------------------------------------------------------------------------
  Position   1 ^a^         2 ^b^                                        
  ---------- ------------- ------------------------------ ------------- ------------------------
  1          \-            \-                             \-            \-

  2          172.7, C      \-                             172.0, C      \-

  3          61.7, CH      4.06, d, (2.4)                 61.9, CH      3.40, d, (4.1)

  4          45.0, CH      3.40, m                        43.6, CH      3.67, m

  5          179.2, C                                     178.3, C      \-

  6          35.8, CH~2~   3.11, dd, (14.7, 5.9)\         35.0, CH~2~   3.10, dd, (13.7, 5.1)\
                           2.87, dd, (14.7, 5.3)                        2.79, dd, (13.7, 8.7)

  7          128.1, C      \-                             128.2, C      \-

  8          131.5, CH     7.10, d, (8.3)                 130.5, CH     6.99, d, (8.7)

  9          116.3, CH     6.77, d, (8.3)                 115.9, CH     6.75 d, (8.7)

  10         157.5, C      \-                             155.4, C      \-

  11         116.3, CH     6.77, d (8.3)                  115.9, CH     6.75, d, (8.7)

  12         131.5, CH     7.10, d (8.3)                  130.5, CH     6.99, d, (8.7)

  13         203.9, C      \-                             202.2, C      \-

  14         52.9, CH      3.62, dd (12.0, 7.0)           52.6, C       3.33, dd, (12.1, 6.9)

  15         51.8, CH      3.10 m                         50.9, CH      2.95, d, (6.9)

  16         130.7, C      \-                             130.1, C      \-

  17         137.1, CH     5.38, s                        135.8, CH     5.29, s

  18         49.1, CH~2~   1.48, m\                       48.3, CH~2~   1.43, m\
                           0.87, m                                      0.86, m

  19         28.1, CH      1.66, m                        27.4, CH      1.61, m

  20         36.5, CH~2~   1.64, m\                       35.6, CH~2~   1.60, m\
                           0.82, m                                      0.77, m

  21         24.1, CH~2~   1.32, m\                       24.3, CH~2~   1.62, m\
                           0.96, m                                      0.75, m

  22         40.8, CH      1.78, ddd, (12.0, 12.0, 2.3)   42.2, CH      1.67, m

  23         36.2, C       \-                             35.2, C       \-

  24         135.7, C      \-                             135.0, C      \-

  25         136.7, CH     5.05, d, (8.2)                 136.1, CH     4.66, d, (9.3)

  26         34.8, CH      2.25, m                        33.9, CH      2.14, m

  27         31.1, CH~2~   1.35, m\                       30.4, CH~2~   1.27, m\
                           1.23, m                                      1.10, m

  28         12.4, CH~3~   0.86, t, (7.6)                 12.1, CH~3~   0.79, t, (7.1)

  29         21.1, CH~3~   0.92, d, (6.2)                 20.9, CH~3~   0.76, d, (6.6)

  30         15.2, CH~3~   1.45, s                        14.5, CH~3~   1.47, s

  31         22.5, CH~3~   1.54, s                        22.2, CH~3~   1.46, s

  32         20.5, CH~3~   0.91, s                        20.3, CH~3~   0.85, s

  33         23.1, CH~3~   0.82, d, (6.4)                 22.8, CH~3~   0.82, d, (6.2)
  ----------------------------------------------------------------------------------------------

^a^ Recorded in Acetone; ^b^ Recorded in CDCl~3~.
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###### 

^1^H and ^13^C NMR Data for compound **3** in CH~3~OD (500 and 125 MHz, *δ* in ppm).

  -----------------------------------------------
  Position   3             
  ---------- ------------- ----------------------
  1          \-            \-

  2          162.0, C      \-

  3          109.9, CH     6.01, s

  4          182.3, C      \-

  4a         115.8, C      \-

  5          143.6, C      \-

  6          118.3, CH     6.64, dd, (2.2, 0.8)

  7          164.0, C      \-

  8          101.8, CH     6.70, d, (2.2)

  8a         161.0, C      \-

  1′         124.8, CH     6.26, ddd,\
                           (15.6, 3.4, 1.7)

  2′         137.3, CH     6.86, ddd,\
                           (15.6, 13.7, 6.9)

  3′         18.6, CH~3~   1.99, dd, (6.9,1.7)

  5- CH~3~   23.1, CH~3~   2.73, s
  -----------------------------------------------
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###### 

Cytotoxic and α-glycosidase inhibitory activities of **1**--**5**.

  Compounds    IC50 (μM)                                               
  ------------ ------------- ------------- ------------- ------------- -------------
  1            \>50          \>50          \>50          \>50          \>500
  2            \>50          29.4 ± 0.35   25.6 ± 0.47   41.7 ± 0.71   \>500
  3            \>50          \>50          \>50          \>50          \>500
  4            14.9 ± 0.21   26.7 ± 1.1    \>50          \>50          78.2 ± 2.1
  5            \>50          \>50          \>50          \>50          49.3 ± 10.6
  Adriamycin   11.5 ± 0.18   11.9 ± 0.37   14.2 ± 0.66   6.66 ± 0.2    ND ^a^
  Acarbose     ND ^a^        ND ^a^        ND ^a^        ND ^a^        275.7 ± 2.7

^a^ Not detected; Values are expressed as mean ± standard deviation (SD); *n* = 3.

[^1]: These authors contributed equally to this work.
